ENFY gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 82 industry peers in the Chemicals industry. ENFY may be in some trouble as it scores bad on both profitability and health. ENFY has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ENFY had negative earnings in the past year.
ENFY had a negative operating cash flow in the past year.
In the past 5 years ENFY always reported negative net income.
In the past 5 years ENFY always reported negative operating cash flow.

1.2 Ratios

ENFY has a worse Return On Assets (-10.96%) than 77.11% of its industry peers.
The Return On Equity of ENFY (-19.41%) is worse than 74.70% of its industry peers.

		Industry Rank	Sector Rank
ROA	-10.96%
ROE	-19.41%
ROIC	N/A

ROA(3y)-24.98%

ROA(5y)-31.96%

ROE(3y)-37.32%

ROE(5y)-45.57%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of ENFY (22.49%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ENFY has remained more or less at the same level.
ENFY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	22.49%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y5.39%

GM growth 5Y-1.28%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ENFY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ENFY has more shares outstanding
ENFY has more shares outstanding than it did 5 years ago.
ENFY has a worse debt/assets ratio than last year.

2.2 Solvency

ENFY has an Altman-Z score of -0.47. This is a bad value and indicates that ENFY is not financially healthy and even has some risk of bankruptcy.
ENFY has a Altman-Z score of -0.47. This is amonst the worse of the industry: ENFY underperforms 87.95% of its industry peers.
ENFY has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ENFY (0.09) is better than 90.36% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.09
Debt/FCF	N/A
Altman-Z	-0.47

ROIC/WACCN/A

WACC7.39%

2.3 Liquidity

ENFY has a Current Ratio of 1.95. This is a normal value and indicates that ENFY is financially healthy and should not expect problems in meeting its short term obligations.
ENFY has a Current ratio (1.95) which is comparable to the rest of the industry.
A Quick Ratio of 1.44 indicates that ENFY should not have too much problems paying its short term obligations.
ENFY's Quick ratio of 1.44 is fine compared to the rest of the industry. ENFY outperforms 61.45% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.95
Quick Ratio	1.44

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ENFY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.52%, which is quite impressive.
ENFY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.70%.
Measured over the past years, ENFY shows a very negative growth in Revenue. The Revenue has been decreasing by -20.10% on average per year.

EPS 1Y (TTM)40.52%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%92.19%

Revenue 1Y (TTM)-20.7%

Revenue growth 3Y-19.14%

Revenue growth 5Y-20.1%

Sales Q2Q%-24.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.